These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
511 related articles for article (PubMed ID: 33509797)
1. Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries'. Al Nokhatha S; MacEoin N; Conway R Ann Rheum Dis; 2021 Oct; 80(10):e170. PubMed ID: 33509797 [No Abstract] [Full Text] [Related]
2. Response to: 'Correspondence on 'Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries' by Nokhatha Dejaco C; Bijlsma JW; Buttgereit F Ann Rheum Dis; 2021 Oct; 80(10):e171. PubMed ID: 33509796 [No Abstract] [Full Text] [Related]
3. Exploring the role of rheumatic and musculoskeletal disease patient organisations during the COVID-19 pandemic: results from the REUMAVID study (phase 1). Garrido-Cumbrera M; Marzo-Ortega H; Christen L; Correa-Fernández J; Sanz-Gómez S; Navarro-Compán V; Clin Exp Rheumatol; 2022 May; 40(5):1062-1063. PubMed ID: 35084328 [No Abstract] [Full Text] [Related]
4. Correspondence on "Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry" by Machado Bourguiba R; Delplanque M; Savey L; Hentgen V; Grateau G; Georgin-Lavialle S; Ann Rheum Dis; 2023 Dec; 82(12):e228. PubMed ID: 35817471 [No Abstract] [Full Text] [Related]
5. Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries. Dejaco C; Alunno A; Bijlsma JW; Boonen A; Combe B; Finckh A; Machado PM; Padjen I; Sivera F; Stamm TA; Buttgereit F Ann Rheum Dis; 2021 Apr; 80(4):518-526. PubMed ID: 33158877 [TBL] [Abstract][Full Text] [Related]
6. Syndemics & syndemogenesis in COVID-19 and rheumatic and musculoskeletal diseases: old challenges, new era. Nikiphorou E; Alpizar-Rodriguez D; Gastelum-Strozzi A; Buch M; Peláez-Ballestas I Rheumatology (Oxford); 2021 May; 60(5):2040-2045. PubMed ID: 33496334 [TBL] [Abstract][Full Text] [Related]
7. EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update. Landewé RBM; Kroon FPB; Alunno A; Najm A; Bijlsma JW; Burmester GR; Caporali R; Combe B; Conway R; Curtis JR; Elkayam O; Gossec L; Heijstek MW; Haupt L; Iagnocco A; Isaacs JD; Juhász IÁ; Makri S; Mariette X; McInnes IB; Mehta P; Mueller-Ladner U; Schulze-Koops H; Smolen JS; Wiek D; Winthrop KL; Navarro-Compán V; Machado PM Ann Rheum Dis; 2022 Dec; 81(12):1628-1639. PubMed ID: 35197264 [TBL] [Abstract][Full Text] [Related]
8. Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV-2/COVID-19 pandemic, including recommendations for COVID-19 vaccination. Specker C; Aries P; Braun J; Burmester G; Fischer-Betz R; Hasseli R; Holle J; Hoyer BF; Iking-Konert C; Krause A; Krüger K; Krusche M; Leipe J; Lorenz HM; Moosig F; Schmale-Grede R; Schneider M; Strangfeld A; Voll R; Voormann A; Wagner U; Schulze-Koops H Z Rheumatol; 2021 Dec; 80(Suppl 2):33-48. PubMed ID: 34491403 [No Abstract] [Full Text] [Related]
9. Correspondence on 'SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists'. Smerilli G; Cipolletta E; Moscioni E; Francioso F; Risa AM; Maccarrone V; Zompa D; Di Matteo A; Di Carlo M; De Angelis R; Salaffi F; Filippucci E; Grassi W Ann Rheum Dis; 2021 Oct; 80(10):e168. PubMed ID: 33962960 [No Abstract] [Full Text] [Related]
10. Recommendations for COVID-19 vaccination in people with rheumatic disease: Developed by the Singapore Chapter of Rheumatologists. Santosa A; Xu C; Arkachaisri T; Kong KO; Lateef A; Lee TH; Leong KH; Low AHL; Sriranganathan MK; Tan TC; Teng GG; Thong BY; Fong W; Lahiri M Int J Rheum Dis; 2021 Jun; 24(6):746-757. PubMed ID: 33973379 [TBL] [Abstract][Full Text] [Related]
11. Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations. Kroon FPB; Najm A; Alunno A; Schoones JW; Landewé RBM; Machado PM; Navarro-Compán V Ann Rheum Dis; 2022 Mar; 81(3):422-432. PubMed ID: 34876462 [TBL] [Abstract][Full Text] [Related]
12. Response to: 'Correspondence on 'SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists'' by Smerilli Priori R; Pellegrino G; Colafrancesco S; Alessandri C; Ceccarelli F; Di Franco M; Riccieri V; Scrivo R; Sili Scavalli A; Spinelli FR; Conti F Ann Rheum Dis; 2021 Oct; 80(10):e169. PubMed ID: 33962963 [No Abstract] [Full Text] [Related]
13. [Updated recommendations of the German Society for Rheumatology for the care of patients with inflammatory rheumatic diseases in the context of the SARS-CoV‑2/COVID‑19 pandemic, including recommendations for COVID‑19 vaccination]. Specker C; Aries P; Braun J; Burmester G; Fischer-Betz R; Hasseli R; Holle J; Hoyer BF; Iking-Konert C; Krause A; Krüger K; Krusche M; Leipe J; Lorenz HM; Moosig F; Schmale-Grede R; Schneider M; Strangfeld A; Voll R; Voormann A; Wagner U; Schulze-Koops H Z Rheumatol; 2021 Aug; 80(6):570-587. PubMed ID: 34309739 [No Abstract] [Full Text] [Related]
14. Impact of COVID-19 pandemic on management of autoimmune and inflammatory diseases in Morocco. Wafa A; Hicham H; Hajar K; Mouna M; Zoubida MT; Mohamed A Pan Afr Med J; 2020; 37():240. PubMed ID: 33552358 [No Abstract] [Full Text] [Related]
15. COVID-19 and the practice of rheumatology in Africa: big changes to services from the shockwave of a pandemic. Akintayo RO; Akpabio A; Kalla A; Dey D; Migowa A; Olaosebikan H; Bahiri R; El Miedany Y; Hadef D; Hamdi W; Oyoo O; Slimani S; Yerima A; Taha Y; Adebajo A; Adelowo O; Tikly M; Ghozlani I; Abdelghani KB; Fouad NA; Mosad D; El Mikkawy D; Abu-Zaid MH; Abdel-Magied RA; Ann Rheum Dis; 2021 Jun; 80(6):e100. PubMed ID: 32611599 [No Abstract] [Full Text] [Related]
16. EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases. Najm A; Nikiphorou E; Kostine M; Richez C; Pauling JD; Finckh A; Ritschl V; Prior Y; Balážová P; Stones S; Szekanecz Z; Iagnocco A; Ramiro S; Sivera F; Dougados M; Carmona L; Burmester G; Wiek D; Gossec L; Berenbaum F RMD Open; 2019; 5(2):e001014. PubMed ID: 31565245 [TBL] [Abstract][Full Text] [Related]
17. Fears and hopes of patients with rheumatic and musculoskeletal diseases during the COVID-19 pandemic across Europe. Results from the REUMAVID study (phase 1 and phase 2). Garrido-Cumbrera M; Christen L; Marzo-Ortega H; Correa-Fernández J; Sanz-Gomez S; Navarro-Compán V Musculoskeletal Care; 2023 Sep; 21(3):932-935. PubMed ID: 36883603 [No Abstract] [Full Text] [Related]
18. COVID-19: autoimmunity, multisystemic inflammation and autoimmune rheumatic patients. Szekanecz Z; Balog A; Constantin T; Czirják L; Géher P; Kovács L; Kumánovics G; Nagy G; Rákóczi É; Szamosi S; Szűcs G; Vályi-Nagy I Expert Rev Mol Med; 2022 Mar; 24():e13. PubMed ID: 35311631 [TBL] [Abstract][Full Text] [Related]
19. Addressing the challenges of the SARS-CoV-2 pandemic in patients affected by autoimmune and rheumatic disease. Robinson PC; Kim AHJ Best Pract Res Clin Rheumatol; 2021 Mar; 35(1):101664. PubMed ID: 33610466 [No Abstract] [Full Text] [Related]
20. The impact of the COVID-19 pandemic on people with rheumatic and musculoskeletal diseases: insights from patient-generated data on social media. Reuter K; Deodhar A; Makri S; Zimmer M; Berenbaum F; Nikiphorou E Rheumatology (Oxford); 2021 Oct; 60(SI):SI77-SI84. PubMed ID: 33629107 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]